STAP Misconduct Investigator Steps Down

One of the RIKEN scientists investigating allegations of misconduct tied to stimulus-triggered acquisition of pluripotency work has resigned from the committee because of anonymous questions raised about his own research.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, JOHN LESTERA RIKEN scientist investigating allegations of misconduct tied to Haruko Obokata and her colleagues’ stimulus-triggered acquisition of pluripotency (STAP) work has resigned from his post on the committee amidst alleged problems with his own published research, the Nature News blog reported. In a statement, molecular biologist Shunsuke Ishii from the RIKEN Advanced Science Institute said he chose to step down from the STAP misconduct investigation committee because of anonymous comments expressing doubt about data in two of his lab’s papers. In his statement, Ishii “deeply apologize[d]” for the inconvenience caused.

Earlier this month (April 1), the RIKEN committee reported evidence of data falsification and fabrication in the STAP papers. While a separate committee is working to determine whether the publications should be retracted and how Obokata might be disciplined for her alleged misconduct, the stem-cell researcher has stood by her results. “At this stage, considering the STAP cell discovery itself to be fabricated is a misunderstanding; I cannot possibly accept this,” Obokata said in an April 1 statement.

Now, Nature reported, Obokata’s lawyer said that questions about the validity of Ishii’s work are reason for a reinvestigation of the initial RIKEN report on STAP. Meanwhile, RIKEN will investigate claims related to Ishii’s research.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo